Section Arrow
XTNT.NYSE-M
- Xtant Medical Holdings
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 0.201
-0.009 (-4.29%)
Bid
0.1949
Ask
0.2675
High 0.21 
Low 0.201 
Volume 203 
Regular Hours (Closed)
Last
 0.21
-0.0061 (-2.82%)
Day High 
0.25 
Prev. Close
0.2161 
1-M High
0.33 
Volume 
257.33K 
Bid
0.1949
Ask
0.2675
Day Low
0.2 
Open
0.25 
1-M Low
0.17 
Market Cap 
30.35M 
Currency 美元 
P/E 32 
%Yield -- 
10-SMA 0.25 
20-SMA 0.27 
50-SMA 0.31 
52-W High 0.84 
52-W Low 0.17 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.11/-0.02
Enterprise Value
44.05M
Balance Sheet
Book Value Per Share
0.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
133.93M
Operating Revenue Per Share
0.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products includeOsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.